HFA Premium Access

Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis

Congress Presentation

About the speaker

Professor Michel Komajda

Groupe Hospitalier Paris Saint-Joseph, Paris (France)
41 presentations
1 follower

11 more presentations in this session

The HF-Wii study: Improving exercise capacity of patients with heart failure through exergaming: Secondary outcomes and per protocol analysis of an international multicenter RCT

Speaker: Professor T. Jaarsma (Linkoping, SE)


Discussion - HF-Wii


Diabetes and obesity in heart failure: a crossroads for prognosis and the efficacy of beta-blockers

Speaker: Professor D. Kotecha (Birmingham, GB)


Discussion - BB-meta-HF


Phase ii trial of pharmacogenetic guided beta-blocker therapy with bucindolol vs. metoprolol for the prevention of atrial fibrillation/flutter in heart failure: GENETIC-AF

Speaker: Professor W. Abraham (Columbus, US)


Access the full session

Late breaking trial II - Chronic heart failure

Speakers: Professor M. Komajda, Professor T. Jaarsma, Professor D. Kotecha, Professor W. Abraham

About the event


Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb